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INTRODUCTION
Myostatin (growth-differentiation factor 8, GDF8) is a member of
the transforming growth factor beta (TGF) superfamily and a
negative regulator of muscle mass. Animals with a polymorphism in
the myostatin gene that renders it less active have hypertrophied
muscles. This is seen in ‘double-muscled’ cattle (Grobet et al., 1997;
Kambadur et al., 1997; McPherron and Lee, 1997), a human child
with significant hypertrophy (Schuelke et al., 2004) and myostatin
knock-out mice (McPherron et al., 1997), all of which demonstrate
extensively hypertrophied muscles in response to myostatin gene
mutation. Even with a normal myostatin gene, if expression is blocked
experimentally, muscles hypertrophy, growing in size by 13–30%
(Whittemore et al., 2003). Conversely, overexpression of myostatin
leads to muscle atrophy (Reisz-Porszasz et al., 2003). Members of
the TGF superfamily bind to membrane receptors and trigger the
phosphorylation and activation of the SMADs (Mothers against
decapentaplegic), a family of signal transducers (Zhu et al., 2004).
TGF family members play a role in many cellular functions and
communications. Different members of the TGF superfamily signal
through various receptors and pathways (for a review, see Ross and
Hill, 2008). Induction of the pathway by either TGF or nodal or
Activin ligands leads to phosphorylation of SMAD2 and SMAD3
(Tsuchida, 2004; Zhu et al., 2004), whereas bone morphogenetic
protein (BMP) and growth and differentiation factor (GDF) ligands
induce phosphorylation of SMAD1, SMAD5 and SMAD8 (Massague
and Gomis, 2006). Activated SMADs form a complex with SMAD4
and are transported to the nucleus to regulate target gene expression.
The myostatin promoter region contains a binding site for this
complex; thus, SMAD2 is both downstream of the
receptor–myostatin complex and upstream of myostatin expression
(Allen and Unterman, 2007). The induction of myostatin expression
by regulatory SMADs was traced unequivocally to SMAD2 protein.
Situations of muscle disuse in mammals typically lead to
increased myostatin mRNA (Reardon et al., 2001) and protein (Shao
et al., 2007). However, how does this response differ in mammalian
hibernators – the champions of muscle mass retention during
extended periods of disuse? During the hibernating season, small
mammals undergo long periods of deep cold torpor (1–2weeks) with
core body temperature (Tb) often close to 0°C (Storey and Storey,
2007) and with little or no skeletal muscle activity (Wickler et al.,
1991). Torpor episodes are interspersed with short periods (<24h)
of arousal when animals rewarm to euthermia. Despite long periods
of inactivity, large hibernators such as bears appear to avoid protein
loss and maintain muscle functional capacity (Harlow et al., 2001;
Lohuis et al., 2007). This phenomenon is not peculiar to bears, as
resistance to atrophy is also found in golden-mantled ground
squirrels (Rourke et al., 2004a; Rourke et al., 2004b), dormice
(Malatesta et al., 2009) and lower vertebrates such as turtles
(McDonagh et al., 2004).
Myonuclei of hibernating dormice are not different from
euthermic controls and apoptosis is not a feature (Malatesta et al.,
2009). Therefore, the control of protein synthesis and degradation
in hibernator muscles is likely pre-transcriptional at the level of cell
signaling, via either activation of growth promoting pathways or
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SUMMARY
Myostatin, a negative regulator of muscle mass, is elevated during disuse and starvation. Mammalian hibernation presents a
unique scenario, where animals are hypocaloric and in torpor, but the extent of muscle protein loss is minimized. We
hypothesized that myostatin expression, which is usually increased early in disuse and under hypocaloric conditions, could be
suppressed in this unique model. Skeletal muscle was collected from thirteen-lined ground squirrels, Spermophilus
tridecemlineatus, at six time points during hibernation: control euthermic (CON); entrance into hibernation (ENT), body
temperature (Tb) falling; early hibernation (EHib), stable Tb in torpor for 24h; late hibernation (LHib), stable Tb in torpor for 3days;
early arousal (EAr), Tb rising; and arousal (AR), Tb restored to 34–37°C for about 18h. There was no significant increase of
myostatin during ENT, EHib or LHib. Unexpectedly, there were approximately sixfold increases in myostatin protein levels as
squirrels arose from torpor. The elevation during EAr remained high in AR, which represented an interbout time period.
Mechanisms that could release the suppression or promote increased levels of myostatin were assessed. SMAD2 and
phosphorylated SMAD2 were increased during EHib, but only the phosphorylated SMAD2 during AR mirrored increases in
myostatin. Follistatin, a negative regulator of myostatin, did not follow the same time course as myostatin or its signaling
pathway, indicating more control of myostatin at the signaling level. However, SMAD7, an inhibitory SMAD, did not appear to play
a significant role during deep hibernation. Hibernation is an excellent natural model to study factors involved in the endogenous
intracellular mechanisms controlling myostatin.
Key words: hibernation, myostatin, skeletal muscle.
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suppression of catabolic processes. Various signaling candidates
have been investigated, for example the AKT/protein kinase B
(PKB) signaling pathway (Abnous et al., 2008) and various mitogen-
activated protein kinases (MAPKs) (Eddy and Storey, 2007;
MacDonald and Storey, 2005). We hypothesized that control of
skeletal muscle mass during hibernation of thirteen-lined ground
squirrels, Spermophilus tridecemlineatus may be linked to changes
in the natural muscle negative regulator, myostatin, and its key
downstream signaling molecules, particularly SMAD2. SMAD2 has
been linked both directly and temporally with myostatin expression
(Shao et al., 2007).
SMAD7 is an inhibitor SMAD and competes with regulatory
SMADs such as SMAD2, resulting in inhibition of TGF and activin
signaling (Nakao et al., 1997). SMAD7 negatively regulates
myostatin signaling (Zhu et al., 2004) and may function as a negative
feedback inhibitor for the pathway (Zhu et al., 2004). Myostatin
function can also be inhibited by binding to the binding protein
follistatin. Follistatin inhibits myostatin activity and, by doing so,
promotes muscle growth (Lee, S. J. et al., 2010). Follistatin binds
directly to myostatin and prevents myostatin binding to its receptor
(Lee and McPherron, 2001). This inhibition is therefore not
dependent on the signaling network. However, even in the absence
of myostatin (myostatin-null mice), overexpression of follistatin
causes a substantial increase in muscle mass revealing that it may
also have an independent effect. These data reveal the complexity
of muscle growth and maintenance through the TGF related
signaling (Lee, 2007). We therefore further hypothesized that
follistatin and SMAD7 would play a role in the complex inhibition
of myostatin alone or the myostatin–SMAD2 pathway.
MATERIALS AND METHODS
Animal collection and hibernation protocol
Thirteen-lined ground squirrels, S. tridecemlineatus (Mitchell 1821),
were captured by a trapper licensed by the United States Department
of Agriculture (TLS Research, Bartlett, IL, USA) using humane
traps. Male squirrels were used for hibernation studies as previously
described; temperature transponders implanted under the skin
allowed body temperature (Tb) to be monitored to identify sampling
times (Bratincsák et al., 2007). Studies took place within the natural
hibernation season (January and February) in the Northern
Hemisphere. Squirrels typically entered their first bout of deep torpor
within 3 to 8days of transfer to the hibernation cold chamber. For
sampling, animals were anesthetized with isoflurane and decapitated
within 2min of removal from the hibernation chamber. Tissues were
rapidly excised, flash frozen in liquid nitrogen, transported to their
destination on dry ice and then stored at –80°C until use. All animal
procedures were approved by the Animal Care and Use Committee
of the National Institute of Neurological Disorders and Stroke
(National Institutes of Health, Bethesda, MD, USA; animal protocol
no. ASP 1223-05). Skeletal muscle (all hindlimb thigh muscles from
each animal homogenized) of thirteen-lined ground squirrels was
sampled at multiple time points over hibernation bouts, as defined
in Bratincsák et al. (Bratincsák et al., 2007): control euthermic
(CON); entrance into hibernation (ENT), with Tb decreasing ranging
from 31 to 18°C (at least two successive temperature readings
showed a decreasing Tb); early hibernation (EHib), animals showed
a stable Tb of 5–8°C for 24h; late hibernation (LHib), animals in
torpor for at least 3days with a stable Tb of 5–8°C; early arousal
(EAr), with Tb rising and increased respiration rate ≥60min–1; and
arousal (AR), with a Tb of at least 34–37°C for about 18h. Note
that CON combined data from two types of control animals, those
housed at room temperature and those that were in the cold room
(4–5°C), which were capable of entering torpor but had not re-
entered hibernation; initial trials found no significant differences
between these groups for any parameter measured.
Tissue preparation
Frozen tissue samples were ground to a powder under liquid nitrogen
and then quickly weighed and homogenized in buffer (1:3 w:v)
(20mmoll–1 HEPES, 200mmoll–1 NaCl, 0.1mmoll–1 EDTA,
10mmoll–1 NaF, 1mmoll–1 Na3VO4, 10mmoll–1 -glycero-
phosphate dissolved in ddH2O) together with 1mmoll–1
phenylmethylsulfonyl fluoride and 1l protease inhibitor (Sigma-
Aldrich, St Louis, MO, USA) using a Polytron PT1000
homogenizer. For SMAD7 and follistatin analysis, samples were
homogenized and lysed [200mmoll–1 HEPES, 5moll–1 NaCl, 10%
Triton X-100, 0.5moll–1 EDTA, 1moll–1 dithiothreitol (DTT), 0.25g
Na-deoxycolate, 0.05g sodium dodecyl sulfate (SDS)]. After
centrifugation for 10min at 10,000g, soluble protein content of the
resulting supernatant was determined using the Bradford method
(Bradford, 1976) and the commercial reagent from Bio-Rad
(Hercules, CA, USA). All samples were adjusted to a set protein
concentration by adding small amounts of the above buffer and then
aliquots (250l) were mixed 1:1 v:v with SDS-PAGE loading buffer
(100mmoll–1 Tris–HCl, pH6.8, 4% w:v SDS, 20% v:v glycerol,
0.2% w:v Bromophenol Blue, 10% v:v 2-mercaptoethanol). The
mixture was boiled for 5min, cooled on ice and frozen at –20°C.
Western blotting
Samples (50g soluble protein) were loaded into each well of 10%
SDS-PAGE gels and separated at 180V for 45min followed by
transfer to polyvinylidene difluoride membranes. Membranes were
blocked for 30min in Tris-buffered saline containing Tween 20
(TBST) (20mmoll–1 Tris base, 140mmoll–1 NaCl, 0.1% Tween 20)
with 2.5% non-fat dried milk added and then incubated at 4°C
overnight with primary antibodies diluted in TBST. Antibodies were
rabbit polyclonal anti-myostatin (1:2000; Millipore, Billerica, MA,
USA), rabbit polyclonal antibodies against SMAD2, phosphorylated
SMAD2, SMAD5 and phosphorylated SMAD1/5 (diluted 1:1000;
Cell Signaling Technology, Danvers, MA, USA). After incubation,
blots were washed three times with TBST and incubated at room
temperature for 30min with secondary anti-rabbit (Cell Signaling
Technology) IgG conjugated to horseradish peroxidase (1:4000
dilution in TBST). Signal detection used enhanced
chemiluminescence (ECL), bands were visualized using a
ChemiGenius imaging system (Syngene, Frederick, MD, USA) and
band intensities were analyzed using the associated Gene Tools
software. Membranes were then stained with Coomassie Blue and
rescanned to confirm equal loading of proteins in each lane; a section
of sharp bands that were present in all samples were scanned and
the densities summed. Intensity of the immunoreactive band in each
lane was normalized to the summed intensity of these Coomassie-
stained bands in the same lane to correct for any slight differences
in loading. The polyclonal myostatin antibody detected a single
protein band (at ~25kDa) corresponding to active myostatin.
Additionally, a very faint band >55kDa was seen, possibly
representing promyostatin. This was not quantified.
For SMAD7 and follistatin proteins, the above protocol was
followed with the following amendments: membranes were
incubated overnight with rabbit anti-follistatin (1:1000, Abcam,
47941, Cambridge, MA, USA) or rabbit anti-SMAD7 (1:1000,
Invitrogen), or -actin (Cell Signaling Technology), incubated with
anti-rabbit secondary antibody for 1h at room temperature (1:1000,
GE Healthcare, Piscataway, NJ, USA). Detection was done using
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ECLTM Western Blotting Detection Reagent (GE Healthcare) and
band analysis was performed with the ImageJ 1.41 software
(http://rsb.info.nih.gov/ij). Each band was normalized to the -actin
serving as control for small differences in loading.
Statistical analysis
Data are presented as means ± s.e.m.; N4 at all time points for all
parameters, except CON (N8). For follistatin and SMAD7, N4
for CON. Mean normalized band densities were compared using
one-way ANOVA and Fisher’s least significant difference (LSD)
post hoc test using SPSS 18.0 (IBM, Armonk, NY, USA). The level
of significance was set at P≤0.05.
RESULTS
The results are an indication of changes in mixed skeletal muscle
samples. The present study analyzed myostatin and total and
phosphorylated levels of SMAD2 at six time points over the course
of a hibernation cycle. Further, the present study measured follistatin
and SMAD7, two possible regulators of myostatin over four time
points of hibernation, and total SMAD5 and phosphorylated levels
of SMAD1 or SMAD5 as a possible alternative to the SMAD2
pathway active throughout hibernation.
Myostatin
Myostatin protein levels during the initial phases, ENT, EHib and
LHib, did not change significantly compared with control values
(Fig.1). However, myostatin protein levels were 4.7-fold above
control values in EAr (P≤0.01) and 3.8-fold above control values
in AR (P≤0.05) groups.
SMAD2 and phosphorylated SMAD2
Total SMAD2 protein increased significantly during EHib by
approximately threefold (P≤0.001 compared with control and P≤0.001
compared with all other groups), but returned to basal levels after
this time point (Fig.2A). Phosphorylated SMAD2 (Fig.2B) also
increased during EHib to approximately fourfold greater levels than
N. E. Brooks, K. H. Myburgh and K. B. Storey
control values (P≤0.001). However, in EAr, protein levels of
phosphorylated SMAD2 rose by approximately fivefold (P≤0.001)
and remained elevated during AR (P≤0.001). Therefore, the extent
of total and phosphorylated SMAD2 had congruent changes during
EHib, but only the extent of phosphorylation was affected during AR.
SMAD7
SMAD7 is an inhibitory SMAD that causes inhibition of the SMAD
signaling pathway (Nakao et al., 1997). ANOVA results suggested
a trend towards a significant group effect (P0.089). No significant
changes in SMAD7 were seen throughout torpor (EHib and LHib)
but post hoc analysis did show that SMAD7 protein levels increased
significantly during AR compared with LHib and EAr (P≤0.05;
Fig.3).
Follistatin
Follistatin is an antagonist of myostatin and functions to inhibit
myostatin (Lee and McPherron, 2001). Follistatin levels increased
by ~1.5-fold during EHib but values returned to baseline levels
during LHib and EAr (Fig.4). There was a significant reduction in
follistatin during AR (P≤0.05 compared with EHib).
SMAD5 and phosphorylated SMAD1/5
Total SMAD5 protein increased significantly during late hibernation
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Fig.1. Myostatin protein levels are maintained at pre-hibernation levels
during hibernation but rise significantly during arousal from torpor in
thirteen-lined ground squirrels. Data are means ± s.e.m.; N4, except CON
N8. Representative band densities, mainly obtained from different blots
with equal protein loading, are presented separately. All bands were
normalized to adjust for slight differences in loading and these values were
used for statistical analysis. ANOVA indicated significant differences
between groups (P≤0.001). LSD post hoc tests: *P≤0.05 compared with
control; ***P≤0.001 compared with control. CON, control euthermic; ENT,
entrance into hibernation; EHib, early hibernation; LHib, late hibernation;





























































Fig.2. (A)Total SMAD2 protein levels are significantly increased during
EHib but subsequently return to basal levels. (B)The amount of
phosphorylated SMAD2 is significantly increased during EHib, EAr and AR.
Skeletal muscle of thirteen-lined ground squirrels was sampled at multiple
time points over hibernation bouts (for abbreviations see Fig.1 legend).
Data are means ± s.e.m.; N4, except CON N8. For description of band
density analysis and representation in this figure, see Fig.1 legend.
ANOVA indicated significant differences between groups (P≤0.001). LSD
post hoc tests: ***P≤0.001 compared with control; $P≤0.001 compared with
all other groups.
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compared with all other groups) but returned to baseline values after
this time point (Fig.5A). In contrast, similar to other signaling
markers, phosphorylated SMAD1/5 (Fig.5B) increased dramatically
during EHib to approximately eightfold greater levels than the
control (P≤0.001 compared with control and P≤0.001 compared with
all other groups) but returned slowly to baseline values during LHib
and EAr (P≤0.05 compared with control).
DISCUSSION
The present study investigated the signaling of myostatin through
the SMAD2 pathway at six time points over the course of a
hibernation bout in thirteen-lined ground squirrels. Because this
signaling could be negatively regulated by SMAD7 or follistatin,
the levels of these proteins were also investigated. Unexpectedly,
myostatin protein levels did not change significantly during the initial
phases of hibernation ENT and EHib, nor did they change during
LHib compared with control values. By contrast, Shao et al. found
immediate increases of myostatin mRNA and protein (within 1day
and sustained for 56days) following denervation (Shao et al., 2007),
which emphasizes the very different intracellular environment in
the skeletal muscle of hibernating rodents compared with models
of skeletal muscle disuse. This highlights that a lack of myostatin
expression during hibernation is unique compared with other
models.
During hibernation, metabolic rate is often reduced by 95% or
more when core body temperatures fall to 0–5°C in mid-winter.
Although there is a thermodynamic component, metabolic rate
depression is largely a regulated process and particularly targets
many energy-expensive cellular processes including a strong global
suppression of the rates of transcription and translation (Morin and
Storey, 2006; Storey and Storey, 2007). Although it would appear
that 90% or more of all genes are suppressed during hibernation,
myostatin protein is neither suppressed nor elevated during early
hibernation and torpor. This finding in mixed muscle reflects that
found in transcript levels of myostatin in gastrocnemius and plantaris
muscles of squirrels (Nowell et al., 2011). However, it is also
important to highlight that a significant decrease in myostatin mRNA
was seen in the diaphragm and soleus muscle (Nowell et al., 2011).
Several key signaling pathways are elevated during hibernation:
in Richardson’s ground squirrels elevated levels of MAPKs 
occurred in skeletal muscle during hibernation, including ERK2,
JNK and phosphorylated p38 MAPK (MacDonald and Storey,
2005). The transcription factor targets (CREB, ATF-2 and Elk-1)
of p38 MAPK also rose, indicating that signaling events are
followed by translation of key factors (Eddy and Storey, 2007). A
common marker of atrophy, the signaling protein MAFbx, is
elevated during hibernation in both the gastrocnemius and plantaris
muscle (Rourke et al., 2004b), but the elevation was not associated
with atrophy itself, which was puzzling. The current data are the
first to provide a potential explanation for catabolic control in
hibernating ground squirrels as there was an absence of myostatin
increase during early hibernation and torpor.
In deep torpor, the state most commonly analyzed in hibernation
studies, both SMAD2 and phosphorylated SMAD2 did not differ
from basal levels. However, because more time points were analyzed
in the present study, we were able to determine that total SMAD2
protein and phosphorylated SMAD2 increased significantly during
EHib. Elevations in total SMAD2 would serve to amplify the
consequences of signals promoting increased SMAD2
phosphorylation, suggesting that this part of the TGF superfamily
signaling cascade may be important in establishing the cold torpid
state.
The second striking result of the present study is the strong
elevation of myostatin protein during EAr and the maintenance of
high myostatin in fully aroused animals sampled ~18h after
reestablishing the euthermic body temperature of ~37°C. A number
of recent publications have highlighted the importance of shivering
during the arousal phase where the hibernating animals return to
normal body temperature for a short period of time. Lee et al.
postulated that the maintenance of muscle mass during hibernation
could be related to the interspersed arousal phases (Lee et al., 2010).
Indeed, the periodic bouts of arousal were associated with increases
in muscle contraction and motor unit activities in hibernating bats
(Lee et al., 2010). However, we have shown that both early arousal
and arousal are accompanied by an increase in myostatin, which
would argue against muscle anabolism stimulated by shivering.
Rather, the low myostatin during early and late hibernation would
argue that the resistance to atrophy is regulated during torpor rather
than during periodic arousal. A possible explanation is an interaction



















CON EHib LHib EAr AR
#
Fig.3. SMAD7 protein levels are maintained during hibernation and
increased during arousal from torpor. Skeletal muscle of thirteen-lined
ground squirrels was sampled at multiple time points over hibernation bouts
(for abbreviations see Fig.1 legend). Data are means ± s.e.m.; N4. For
description of band density analysis and representation in this figure, see
Fig.1 legend. ANOVA indicated a trend of difference between groups
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
Fig.4. Follistatin protein levels are reduced during arousal from torpor.
Skeletal muscle of thirteen-lined ground squirrels was sampled at multiple
time points over hibernation bouts (for abbreviations see Fig.1 legend).
Data are means ± s.e.m.; N4. For description of band density analysis
and representation in this figure, see Fig.1 legend. ANOVA indicated
significant differences between groups (P≤0.05). LSD post hoc tests:
^P≤0.05 compared with EAr and Ar; P≤0.05 compared with EHib.
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known stimulus for muscle atrophy and here it is important to note
that the atrophic effect of dexamethasone treatment in mice can be
completely abolished by myostatin knock-out (Gilson et al., 2007).
It is intriguing that myostatin translation is activated in EAr, much
sooner than the resumption of normal body temperature. There is
a clear congruence during EAr and AR phases of the hibernation
cycle between phosphorylated SMAD2 and myostatin protein
levels; both increased dramatically (fivefold to sixfold) when
animals arose from torpor. This suggests a myostatin-initiated
increase in SMAD2 phosphorylation because it is known that
myostatin acts through the SMAD2 pathway. Although SMAD2 is
a signaling protein downstream of myostatin, overexpression of
SMAD2 also increases myostatin expression (Allen and Unterman,
2007), suggesting that a positive feedback loop
(myostatin–SMAD2–myostatin) operates under certain conditions,
including hibernation. However, we did not observe this positive
feedback loop during early hibernation or deep torpor: the increase
in SMAD2 protein and phosphorylation levels in EHib were not
accompanied by any substantial increase in myostatin. Therefore,
other mechanisms must exist to prevent its downstream effect on
myostatin transcription and/or translation during entry into and
during torpor.
N. E. Brooks, K. H. Myburgh and K. B. Storey
Inhibition of the SMAD-complex translocation to the nucleus is
a possible explanation. There is a precedent in the literature for
decreased SMAD2 translocation under pathological conditions such
as Alzheimer’s disease, where phosphorylated SMAD2 is elevated
in neuronal cytoplasm, but without concomitant nuclear localization
(Lee et al., 2006). Hibernation may also cause uncoupling of this
pathway.
It is known that follistatin may prevent myostatin from binding
to its receptor (Lee and McPherron, 2001). We found that increased
myostatin in AR occurred alongside a significant reduction in
follistatin. Therefore, instead of the follistatin protein–protein
interaction with myostatin preventing the actions of myostatin
(Amthor et al., 2004), the reduction in follistatin found here would
serve to further enhance the response to elevated myostatin during
AR. The reduction in follistatin followed after the increase in
myostatin, possibly indicating separate mechanisms of control.
However, increased phosphorylated SMAD2 mirrored increased
myostatin, and did not change when follistatin was reduced in AR.
The reduction in follistatin may therefore have an effect on
alternative pathways such as the AKT pathway (Trendelenburg et
al., 2009). It has also been reported that follistatin increases satellite
cell proliferation, possibly by blocking myostatin (Gilson et al.,
2009). A recent study reported no change in muscle fibre shape and
size or fibre type during hibernation (Malatesta et al., 2009).
Furthermore, they also reported that nuclear and mitochondrial
activity is maintained during deep torpor (measurement of one time
point during hibernation). Further investigation is warranted to
investigate mitochondria, myonuclei and satellite cell nuclei during
AR.
SMAD7 is an inhibitory SMAD. Transcription of SMAD7 is
initiated by both TGF and activation provides a regulatory feedback
mechanism to terminate signaling through the activated receptors
(Nakao et al., 1997). We report increased levels of SMAD7 during
AR from hibernation. The increased SMAD7 levels may be
indicative of an inhibitory control in response to the increased
myostatin levels at this time point. Although this response is delayed
compared with the myostatin increase in EAr, it could compensate
for the reduced follistatin levels at the same time point. Importantly,
SMAD7 does not appear to play any inhibitory role during EHib
or LHib.
We also report changes in SMAD5 and phosphorylated SMAD1/5
levels during hibernation. There are a number of signaling pathways
influenced by different members of the TGF superfamily. In
comparison to myostatin’s signaling through the SMAD2 cascade,
BMP ligands act by inducing phosphorylation of SMAD1, SMAD5
and SMAD8 (Massague and Gomis, 2006). Levels of
phosphorylated SMAD1/5 follow a similar time course to SMAD2
with elevated levels at EHib. This may be further indicative of
important changes that the muscle undergoes in adaption to the cold
torpid state and suggests that these changes result in a response in
members of the TGF superfamily. SMAD5 protein levels were
increased in deep torpor, in contrast to all of the other measures in
this study, including SMAD2. Previous studies have shown
inconsistencies with total protein and phosphorylated protein levels;
for example, Abnous et al. found no change in AKT protein levels
whereas activated phosphorylated AKT was reduced by
approximately 40% in skeletal muscle of hibernating Richardson’s
ground squirrels compared with euthermic controls (Abnous et al.,
2008). The animal may display a disparate response as hibernation
progresses, particularly during deep torpor. The results of this study
also demonstrate the complex interplay of the various SMAD




























































Fig.5. (A)Total SMAD5 protein levels are significantly increased during
LHib but subsequently return to basal levels. (B)The amount of
phosphorylated SMAD1/5 is significantly increased during EHib. Skeletal
muscle of thirteen-lined ground squirrels was sampled at multiple time
points over hibernation bouts (for abbreviations see Fig.1 legend). Data are
means ± s.e.m.; N4, except CON N8. For description of band density
analysis and representation in this figure, see legend to Fig.1. ANOVA
indicated significant differences between groups (P≤0.001). LSD post hoc
tests: *P≤0.05 compared with control; ***P≤0.001 compared with control;
$P≤0.001 compared with all other groups.
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Conclusions
In conclusion, mammals generally lack the ability to prevent
significant atrophy. Increases in myostatin have been associated with
conditions that promote muscle protein loss. Here we present data
that clearly indicate that myostatin expression in our model is
different from the currently accepted dogma for other mammals.
Therefore, ground squirrels and other hibernating species can
provide a natural model to study mechanisms for myostatin
regulation.
Clearly, the evidence is mounting that: (1) during torpor, skeletal
muscle retains significant intracellular activity, even at very low Tb
values; (2) this activity exhibits variations when multiple time points
are assessed throughout the various stages of hibernation and arousal;
(3) the TGF superfamily signaling molecule SMAD2, although
known to be related to myostatin, does not follow the same temporal
pattern except during the arousal phases of the cycle; (4) myostatin
is inhibited during torpor, but rises when animals undergo arousal,
remaining high; and (5) follistatin does not follow the same time
course as myostatin or its signaling components, indicating that
control of myostatin does not occur by inhibiting its receptor binding
but is more likely to occur at the signaling level. In addition, SMAD7
does not appear to play a significant inhibitory role during deep
hibernation.
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